Search results
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 15 hours agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
Study shows new cancer vaccine to treat melanoma has 96% survival rate
UNILAD· 7 days agoA new vaccine treatment for skin cancer melanoma has shown extremely promising results in a new ...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 1 day agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Covid-flu combination vaccine shows positive results in late-stage trial, Moderna says
CNN.com· 1 day agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 1 day agoAnd there could be more to come -- much more. The company has already announced positive results from a late-stage study of its influenza vaccine
How a blunder by a respected medical journal is fueling an anti-vaccine lie
LA Times via Yahoo News· 4 hours agoA British Medical Journal paper about COVID deaths has been touted by the anti-vaccine camp, but...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 18 hours agovaccine includes elements of MRNA-1010, the seasonal flu shot, and its next-generation Covid shot, ...
Moderna sees positive results in COVID-flu vaccine trial
The Hill via Yahoo News· 23 hours agoModerna’s late-stage trial for its COVID-flu combination vaccine yielded positive results, the...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 6 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 22 hours agoCruz, UK medical director at Moderna, said: “The phase three trial results for mRNA-1083, Moderna’s...